Creutzfeldt-Jakob disease with neuroleptic malignant syndrome

Čiauškaitė, Julija; Puleikytė, Ieva; Jesmanas, Simonas; Jurkevičienė, Giedrė; Vaitkus, Antanas; Rastenytė, Daiva

doi:10.1002/ccr3.4699

Use this url to cite publication: https://hdl.handle.net/20.500.12512/111821

Creutzfeldt-Jakob disease with neuroleptic malignant syndrome

Details

Type of publication

Straipsnis Web of Science duomenų bazėje / Article in Web of Science database (S1a)

Author(s)

Author	Affiliation
Čiauškaitė, Julija	MF Neurologijos klinika (04.29)
Puleikytė, Ieva	MF Neurologijos klinika (04.29)
Jesmanas, Simonas	MF Radiologijos klinika (04.36)
Jurkevičienė, Giedrė	MF Neurologijos klinika (04.29)
Vaitkus, Antanas	MF Neurologijos klinika (04.29)
Rastenytė, Daiva	MF Neurologijos klinika (04.29)

Title

Creutzfeldt-Jakob disease with neuroleptic malignant syndrome

Julija Čiauškaitė, Ieva Puleikytė, Simonas Jesmanas, Giedrė Jurkevičienė, Antanas Vaitkus, Daiva Rastenytė

Publisher (trusted)

Wiley

Is Referenced by

Emerging Sources Citation Index (Web of Science)

PubMed

Date Issued

Date
2021-08-24

Extent

p. 1-7.

Is part of

Clinical case reports. Hoboken : Wiley, 2021, vol. 9, no. 8.

Version

Originalus / Original

Description

art. no. e04699

Research Area

Medicinos ir sveikatos mokslai / Medical and health sciences (M)

Field of Science

Medicina / Medicine (M001)

Keywords (en)

Abstract (en)

Creutzfeldt- Jakob disease (CJD) is a rare rapidly prograssive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. WE present a case of a 51-year- old woman with CJD who developed NMS after being prescribed quetiapine.